Literature DB >> 15334606

Modulation of CREB expression and phosphorylation in the rat nucleus accumbens during nicotine exposure and withdrawal.

Olivera Pluzarev1, Subhash C Pandey.   

Abstract

The nucleus accumbens region of the brain has been shown to play a role in reward and reinforcing mechanisms of drugs of abuse. To understand the molecular mechanisms of nicotine addiction, the present investigation examined the effects of acute and chronic nicotine treatment and its withdrawal on cAMP-responsive element binding (CREB) protein expression and phosphorylation (serine-133) in nucleus accumbens (NAc) structures of rats. it was found that acute treatment (1 and 18 hr of withdrawal) with nicotine had no effects on total creb and phosphorylated CREB (p-CREB) protein levels in shell or core structures of rat NAc. On the other hand, 18-hr withdrawal after chronic nicotine exposure produced significant reductions in the total CREB and p-CREB protein levels in the shell but not in core structures of nac. interestingly, nicotine withdrawal (1 hr) after chronic exposure maintained normal levels of total CREB and p-CREB protein levels in the shell and core structures of NAc. These results suggest the possibility that decreased CREB activity in the shell of NAc may be associated with abnormal reward mechanisms during nicotine withdrawal after chronic exposure.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15334606     DOI: 10.1002/jnr.20216

Source DB:  PubMed          Journal:  J Neurosci Res        ISSN: 0360-4012            Impact factor:   4.164


  19 in total

Review 1.  Life-long hippocampal neurogenesis: environmental, pharmacological and neurochemical modulations.

Authors:  Eleni Paizanis; Sabah Kelaï; Thibault Renoir; Michel Hamon; Laurence Lanfumey
Journal:  Neurochem Res       Date:  2007-04-04       Impact factor: 3.996

Review 2.  Nicotine and hippocampus-dependent learning: implications for addiction.

Authors:  Thomas J Gould
Journal:  Mol Neurobiol       Date:  2006-10       Impact factor: 5.590

3.  Atomoxetine reverses nicotine withdrawal-associated deficits in contextual fear conditioning.

Authors:  Jennifer A Davis; Thomas J Gould
Journal:  Neuropsychopharmacology       Date:  2007-01-17       Impact factor: 7.853

Review 4.  Cellular events in nicotine addiction.

Authors:  Rachel E Penton; Robin A J Lester
Journal:  Semin Cell Dev Biol       Date:  2009-01-20       Impact factor: 7.727

Review 5.  Transcriptional and epigenetic mechanisms of addiction.

Authors:  Alfred J Robison; Eric J Nestler
Journal:  Nat Rev Neurosci       Date:  2011-10-12       Impact factor: 34.870

6.  Regulation of anxiety and initiation of sexual behavior by CREB in the nucleus accumbens.

Authors:  Michel Barrot; Deanna L Wallace; Carlos A Bolaños; Danielle L Graham; Linda I Perrotti; Rachael L Neve; Heather Chambliss; Jerry C Yin; Eric J Nestler
Journal:  Proc Natl Acad Sci U S A       Date:  2005-05-27       Impact factor: 11.205

7.  Diurnal variation in nicotine sensitivity in mice: role of genetic background and melatonin.

Authors:  Sharon Mexal; William J Horton; Eric L Crouch; Sheila I B Maier; Andra L Wilkinson; Marisa Marsolek; Jerry A Stitzel
Journal:  Neuropharmacology       Date:  2012-07-20       Impact factor: 5.250

8.  Ro 32-0432 attenuates mecamylamine-precipitated nicotine withdrawal syndrome in mice.

Authors:  Thakur Gurjeet Singh; Ashish K Rehni; Sandeep Arora
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2012-12-29       Impact factor: 3.000

9.  Nucleus accumbens CREB activity is necessary for nicotine conditioned place preference.

Authors:  Darlene H Brunzell; Yann S Mineur; Rachael L Neve; Marina R Picciotto
Journal:  Neuropsychopharmacology       Date:  2009-02-11       Impact factor: 7.853

10.  Nicotine-conditioned place preference induced CREB phosphorylation and Fos expression in the adult rat brain.

Authors:  Mariano M Pascual; Veronica Pastor; Ramon O Bernabeu
Journal:  Psychopharmacology (Berl)       Date:  2009-08-27       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.